A. Dilawari

发表

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer

C. Isaacs, P. Pohlmann, A. Shajahan-Haq, 2018, Contemporary clinical trials communications.

Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study

A. Saykin, B. McDonald, C. Isaacs, 2022, Breast Cancer Research and Treatment.

Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer

V. Sheppard, C. Dash, L. Cavalli, 2017, Clinical breast cancer.

Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study

A. Saykin, B. McDonald, C. Isaacs, 2022, Breast Cancer Research and Treatment.

Loneliness and mental health during the COVID‐19 pandemic in older breast cancer survivors and noncancer controls

A. Saykin, B. McDonald, J. Mandelblatt, 2021, Cancer.

Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.

A. Saykin, B. McDonald, J. Mandelblatt, 2022, Journal of geriatric oncology.

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer

C. Isaacs, M. Tan, P. Pohlmann, 2021, Cancer.

HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane

C. Isaacs, M. Tan, S. Swain, 2022, Breast Cancer Research and Treatment.

Intracranial Rosai-Dorfman: A Clinical Challenge

R. Said, A. Dilawari, J. Talwar, 2011, The neurologist.

Lung cancer trends: smoking, obesity, and sex assessed in the Staten Island University’s lung cancer patients

V. Bhatt, Shilpi Gupta, Houssein Abdul Sater, 2014, International journal of general medicine.

Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.

C. Isaacs, V. Sheppard, S. O’Neill, 2015, Clinical breast cancer.

J. VanMeter, A. Saykin, B. McDonald, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.

A. Saykin, B. McDonald, C. Isaacs, 2019, Journal of pain and symptom management.

Pre-treatment psychoneurological symptoms and their association with longitudinal cognitive function and quality of life in older breast cancer survivors

A. Saykin, B. McDonald, C. Isaacs, 2018 .

Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype

A. Saykin, B. McDonald, C. Isaacs, 2019, Cancer.

Video intervention increases participation of black breast cancer patients in therapeutic trials

S. Swain, M. Mete, P. Pohlmann, 2017, npj Breast Cancer.

Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer Survivors

A. Saykin, B. McDonald, J. Mandelblatt, 2021, Research square.

Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID‐19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study

A. Saykin, B. McDonald, J. Mandelblatt, 2022, Cancer medicine.

Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?

R. Paxman, C. Dash, L. Adams-Campbell, 2021, The oncologist.

Providers’ perspectives on adherence to hormonal therapy in breast cancer survivors. Is there a role for the digital health feedback system?

V. Sheppard, J. Turner, Alejandra Hurtado-de-Mendoza, 2018, Health and Technology.

Providers’ perspectives on adherence to hormonal therapy in breast cancer survivors. Is there a role for the digital health feedback system?

V. Sheppard, J. Turner, Alejandra Hurtado-de-Mendoza, 2018, Health and Technology.

Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors

A. Saykin, H. Jim, B. Small, 2021, Breast Cancer Research and Treatment.

A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density.

G. Ursin, C. Checka, H. Toth, 2012, Anticancer research.

US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer

R. Pazdur, L. Amiri-Kordestani, M. Kondratovich, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study

H. Cohen, A. Saykin, B. McDonald, 2019, Cancer.

Highlights of FDA Oncology Approvals in 2022: Tissue-Agnostic Indications, Dosage Optimization, and Diversity in Drug Development.

K. Goldberg, R. Pazdur, G. Pamuk, 2022, Cancer discovery.

Video intervention increases participation of black breast cancer patients in therapeutic trials

S. Swain, M. Mete, P. Pohlmann, 2017, npj Breast Cancer.

FDA Approval Summary: Mirvetuximab soravtansine-gynx for FRα-positive, Platinum-Resistant Ovarian Cancer.

R. Pazdur, R. Pragani, H. Gittleman, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers

J. Cangiarella, F. Muggia, A. Downey, 2008, Ecancermedicalscience.